27623486|t|From Zirconium Nanograins to Zirconia Nanoneedles
27623486|a|Combinations of three simple techniques were utilized to gradually form zirconia nanoneedles from zirconium nanograins. First, a physical vapor deposition magnetron sputtering technique was used to deposit pure zirconium nanograins on top of a substrate. Second, an anodic oxidation was applied to fabricate zirconia nanotubular arrays. Finally, heat treatment was used at different annealing temperatures in order to change the structure and morphology from nanotubes to nanowires and subsequently to nanoneedles in the presence of argon gas. The size of the pure zirconium nanograins was estimated to be approximately 200-300 nm. ZrO2 nanotubular arrays with diameters of 70-120 nm were obtained. Both tetragonal and monoclinic ZrO2 were observed after annealing at 450 °C and 650 °C. Only a few tetragonal peaks appeared at 850 °C, while monoclinic ZrO2 was obtained at 900 °C and 950 °C. In assessing the biocompatibility of the ZrO2 surface, the human cell line MDA-MB-231 was found to attach and proliferate well on surfaces annealed at 850 °C and 450 °C; however, the amorphous ZrO2 surface, which was not heat treated, did not permit extensive cell growth, presumably due to remaining fluoride.
27623486	5	14	Zirconium	T196	C0043506
27623486	15	25	Nanograins	T073	C1450053
27623486	29	37	Zirconia	T121,T197	C0078814
27623486	38	49	Nanoneedles	T073	C1450053
27623486	79	89	techniques	T169	C0449851
27623486	122	130	zirconia	T121,T197	C0078814
27623486	131	142	nanoneedles	T073	C1450053
27623486	148	157	zirconium	T196	C0043506
27623486	158	168	nanograins	T073	C1450053
27623486	179	204	physical vapor deposition	T170	C0025663
27623486	205	235	magnetron sputtering technique	T169	C0449851
27623486	261	270	zirconium	T196	C0043506
27623486	271	281	nanograins	T073	C1450053
27623486	294	303	substrate	T167	C3891814
27623486	316	332	anodic oxidation	T044	C0030011
27623486	358	366	zirconia	T121,T197	C0078814
27623486	367	378	nanotubular	T073	C1257851
27623486	379	385	arrays	T082	C1510941
27623486	396	400	heat	T070	C0018837
27623486	401	410	treatment	T169	C1522326
27623486	433	442	annealing	T067	C0870079
27623486	443	455	temperatures	T081	C0039476
27623486	479	488	structure	T082	C0678594
27623486	493	503	morphology	T080	C0332437
27623486	509	518	nanotubes	T073	C1257851
27623486	522	531	nanowires	T073	C1721063
27623486	552	563	nanoneedles	T073	C1450053
27623486	583	588	argon	T196	C0003781
27623486	589	592	gas	T104	C0017110
27623486	598	602	size	T082	C0456389
27623486	615	624	zirconium	T196	C0043506
27623486	625	635	nanograins	T073	C1450053
27623486	682	686	ZrO2	T121,T197	C0078814
27623486	687	698	nanotubular	T073	C1257851
27623486	699	705	arrays	T082	C1510941
27623486	711	720	diameters	T081	C1301886
27623486	754	764	tetragonal	T082	C1254362
27623486	769	779	monoclinic	T082	C1254362
27623486	780	784	ZrO2	T121,T197	C0078814
27623486	805	814	annealing	T067	C0870079
27623486	848	864	tetragonal peaks	T080	C0444505
27623486	891	901	monoclinic	T082	C1254362
27623486	902	906	ZrO2	T121,T197	C0078814
27623486	959	975	biocompatibility	T044	C0596177
27623486	983	987	ZrO2	T121,T197	C0078814
27623486	988	995	surface	T082	C0205148
27623486	1001	1016	human cell line	T025	C0682523
27623486	1017	1027	MDA-MB-231	T050	C3898556
27623486	1072	1080	surfaces	T082	C0205148
27623486	1081	1089	annealed	T067	C0870079
27623486	1125	1134	amorphous	T080	C1979848
27623486	1135	1139	ZrO2	T121,T197	C0078814
27623486	1140	1147	surface	T082	C0205148
27623486	1159	1175	not heat treated	T033	C0243095
27623486	1202	1213	cell growth	T043	C0007595
27623486	1243	1251	fluoride	T121,T197	C0016327